Top Markets
#1 Resolv wstUSR Resolv wstUSR +114.56%
#2 Luxxcoin Luxxcoin +46.85%
#3 Layer3 Layer3 +32.82%
#4 ResearchCoin ResearchCoin +31.78%
#5 Reactive Network Reactive Network +24.01%
#6 Orderly Network Orderly Network +17.27%
#7 Bitgert Bitgert +17.01%
#8 Lisk Bridged wstETH (Lisk) Lisk Bridged wstETH (Lisk) +10.20%
#9 Useless Coin Useless Coin +10.11%
#10 OpenVPP OpenVPP +9.68%
Coin of the day
Resolv wstUSR Resolv wstUSR
Settings
Language
ENGLISH
Currency
USD
Theme
CSL Limited CSL Limited

CSL Limited

CSL
Rank in Stocks #432
CSL Limited researches, develops, manufactures, markets, and distributes... CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.
Share Price
$99.32
Market Cap
$48.20B
Change (1 day)
0.98%
Change (1 year)
-32.14%
Country
AU
Trade CSL Limited (CSL)

Category

Healthcare
Dividend history for CSL Limited (CSL)
CSL Limited (stock symbol: CSL) made a total of 64 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $40.42
Dividend yield (TTM) : 0.03
Dividend payments for CSL Limited (CSL) from 1994 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
2026 (TTM) $1.85 -59.20%
2025 $4.52 13.84%
2024 $3.97 9.48%
2023 $3.63 14.09%
2022 $3.18 8.25%
2021 $2.94 -0.07%
2020 $2.94 10.65%
2019 $2.66 16.41%
2018 $2.28 30.24%
2017 $1.75 3.04%
2016 $1.70 3.50%
2015 $1.64 32.85%
2014 $1.24 17.12%
2013 $1.06 27.28%
2012 $0.83 3.75%
2011 $0.8 0.00%
2010 $0.8 14.29%
2009 $0.7 52.17%
2008 $0.46 32.72%
2007 $0.3466 52.96%
2006 $0.2266 151.78%
2005 $0.09 -28.97%
2004 $0.1267 11.83%
2003 $0.1133 0.00%
2002 $0.1133 30.68%
2001 $0.0867 13.04%
2000 $0.0767 9.57%
1999 $0.07 16.67%
1998 $0.06 16.28%
1997 $0.0516 18.89%
1996 $0.0434 8.50%
1995 $0.04 139.52%
1994 $0.0167 0.00%
List of all dividend payments
Year Dividend Change
2026 (TTM) $1.85 -59.20%
2025 $4.52 13.84%
2024 $3.97 9.48%
2023 $3.63 15.74%
2022 $3.14 6.70%
2021 $2.94 -0.07%
2020 $2.94 10.65%
2019 $2.66 16.41%
2018 $2.28 30.24%
2017 $1.75 3.04%
2016 $1.70 3.50%
2015 $1.64 32.85%
2014 $1.24 17.12%
2013 $1.06 27.28%
2012 $0.83 2.66%
2011 $0.8085 -1.55%
2010 $0.8212 17.31%
2009 $0.7 52.17%
2008 $0.46 -60.27%
2007 $1.16 70.28%
2006 $0.68 144.96%
2005 $0.2776 -26.95%
2004 $0.38 11.76%
2003 $0.34 0.00%
2002 $0.34 30.77%
2001 $0.26 13.04%
2000 $0.23 9.52%
1999 $0.21 16.67%
1998 $0.18 16.13%
1997 $0.155 19.23%
1996 $0.13 8.33%
1995 $0.12 140.00%
1994 $0.05 0.00%
Dividend payments for similar companies or competitors
Company Number of dividend payments Country
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
52.00%
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
0.00%
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
5.00%
US
UCB SA UCB SA
UCB SA
UCB.BR
29.00%
BE
Argenx SE Argenx SE
Argenx SE
ARGX.US
0.00%
NL